Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.12M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2.48M
-
Shares change
-
-210K
-
Total reported value, excl. options
-
$23.3M
-
Value change
-
-$1.87M
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$9.40
Significant Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q1 2022
34 filings reported holding LUMO - LUMOS PHARMA INC - Common Stock as of Q1 2022.
LUMOS PHARMA INC - Common Stock (LUMO) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.48M shares
of 8.12M outstanding shares and own 30.55% of the company stock.
Largest 10 shareholders include Blackstone Inc. (468K shares), GOLDMAN SACHS GROUP INC (356K shares), WELLS FARGO & COMPANY/MN (318K shares), RENAISSANCE TECHNOLOGIES LLC (272K shares), VANGUARD GROUP INC (238K shares), NEA Management Company, LLC (168K shares), PRICE T ROWE ASSOCIATES INC /MD/ (160K shares), Jefferies Group LLC (121K shares), BlackRock Inc. (59.5K shares), and Lion Point Capital, LP (51.2K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.